Valuation: Abbott Laboratories

Market Cap 183B 159B 148B 136B 257B 17,460B 261B 1,744B 685B 8,692B 687B 672B 29,147B P/E 2026 *
30.3x
P/E 2027 * 23.4x
Enterprise Value 207B 180B 168B 154B 290B 19,767B 295B 1,975B 775B 9,841B 778B 761B 32,998B EV / Sales 2026 *
4.12x
EV / Sales 2027 * 3.74x
Free-Float
86.16%
Yield 2026 *
2.44%
Yield 2027 * 2.59%
1 day-3.41%
1 week+0.59%
1 month+14.09%
3 months+18.88%
6 months-13.27%
Current year-14.14%
1 week 84.5
Extreme 84.5
88
1 month 73
Extreme 73
88
Current year 65
Extreme 65
100
1 year 65
Extreme 65
102
3 years 65
Extreme 65
106
5 years 65
Extreme 65
128
10 years 34.75
Extreme 34.75
128
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5-day change 1-year change 3-year change Capi.($)
-3.41%+0.59% - - 183B
-0.37%+2.62%-5.37%-2.70% 109B
-0.29%+0.47%+8.83%+66.58% 60.57B
+3.50%+0.47%+28.65%+49.27% 51.8B
+0.10%+5.92%-7.09%-40.56% 45.64B
+0.41%+1.37% - - 33.22B
+11.95%+16.65%+3.32%-33.00% 31.49B
+0.40%+3.89%+42.51%-7.36% 24B
-1.22%+6.69%+0.84%+1.26% 22.26B
-3.79%+7.37%-9.25%-0.06% 21.51B
Average +0.73%+5.39%+7.80%+4.18% 44.42B
Weighted average by Cap. -0.35%+4.12%+5.60%+8.87%

Financials

2026 *2027 *
Net sales 50.3B 43.73B 40.7B 37.37B 70.57B 4,802B 71.66B 480B 188B 2,391B 189B 185B 8,016B 54.65B 47.51B 44.22B 40.6B 76.66B 5,217B 77.85B 521B 205B 2,597B 205B 201B 8,709B
Net income 6.25B 5.44B 5.06B 4.65B 8.77B 597B 8.91B 59.66B 23.41B 297B 23.49B 22.97B 997B 7.92B 6.89B 6.41B 5.89B 11.12B 756B 11.29B 75.57B 29.66B 377B 29.76B 29.1B 1,263B
Net Debt 24.17B 21.01B 19.55B 17.95B 33.9B 2,307B 34.43B 230B 90.46B 1,148B 90.76B 88.76B 3,851B 21.42B 18.62B 17.33B 15.91B 30.04B 2,044B 30.51B 204B 80.17B 1,018B 80.43B 78.66B 3,413B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change
26-07-31 CHF 85.00 -.--%
26-07-30 CHF 85.00 -3.41%
26-07-29 CHF 88.00 -.--%
26-07-28 CHF 88.00 +4.14%
26-07-27 CHF 84.50 -.--%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
105.70USD
Average target price
118.42USD
Spread / Average Target
+12.03%

Quarterly revenue - Rate of surprise